ClinicalTrials.gg
Active, not recruitingNCT05216003PATH4YOUUpdated Apr 8, 2026

Pregnancy at a Time That Is Happy and Healthy for You

An interventional study of PATH4YOU in Contraception Behavior, sponsored by Indiana University. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by Indiana University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2021, registered Jan 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
1,200
Allocation
Non-randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

In an effort reduce maternal and infant mortality and health disparities overall, PATH4YOU (Pregnancy At a Time that's Healthy and Happy for You) will be implemented starting in Marion County, and will ultimately be a statewide comprehensive contraceptive access program that ensures that patient-centered counseling and same-day access to no (or low) cost contraception are delivered to women across the state. The goal of this project is to partner with community stakeholders to tailor and implement a patient-centered, comprehensive contraceptive access intervention, the PATH4YOU Bundle.

The health center level intervention will consist of three key principles:

  1. Pregnancy Intention Screening: Provide training for health care providers and assist in health center implementation of a patient-centered pregnancy intention screening strategy within clinical settings
  2. Contraception and Reproductive Health Counseling: Implement the use of a pre-visit patient-centered decision-aid for all patients presenting to a health center for reproductive health care.
  3. Same-Day Access to Contraception: Provide training for health care providers and logistical assistance to health centers to implement care consistent with providing patients with their chosen method of contraception the day of patient contact.
02

Conditions studied

  • Contraception Behavior
03

In context

Contraception Behavior

132 studies on the registry are indexed under Contraception Behavior; 20 are open to participants now.

This study's enrollment of 1,200 is above the median of 382 across 106 interventional studies indexed under Contraception Behavior.

Browse Contraception Behavior studies →

Lead sponsor

Indiana University is the lead sponsor of 986 studies on the registry; 198 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 118 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women age 18-49
  • presenting for care at PATH4YOU clinic site

Exclusion criteria

Exclusion Criteria:

  • history of hysterectomy or sterilization, or
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,200 participants (actual)

Study arms

  • Experimental
    PATH4YOU County

    Behavioral: PATH4YOU

  • No intervention
    Matched-Pair Control County

Interventions

  • BehavioralPATH4YOU

    PATH4YOU offers patient-center, comprehensive, contraceptive counseling; pregnancy planning; and same to next day access to birth control. This clinical care program will reduce obstacles to contraception in Indiana and enables access to healthy pregnancy planning conversations.

06

What researchers measure

Primary outcomes

  1. Participant Satisfaction with Shared Decision Making

    Participant satisfaction is measured by the validated CollaboRATE scale, which is a 3 question survey. Each question is rated on a 5 point Likert scale with a response range of "every effort was made" (1) to "no effort was made" (5).

    Time frame: Within 2-4 weeks of PATH4YOU service visit

  2. Participant Satisfaction with Same Day Contraception

    Participants will be asked to respond to a single question of whether they received their desired contraception on the day of the visit. Responses will be either yes or no.

    Time frame: Within 2-4 weeks of PATH4YOU service visit

  3. Quality of family planning services

    Quality of family planning services will be evaluated through the validated Patient Centered Contraceptive Counseling (PCCC) Measure. The PCCC is a 4 question survey. Each question is rated on a 5 point Likert scale with responses ranging from poor (1) to excellent (5). Individual participant scores may range from 4 to 20 (with higher scores reflecting higher quality of care). A proportion of patient responses (80%) is used to determine overall quality of services. Participants will be asked to complete the PCCC one time, within 2-4 weeks after they have received care through the PATH4YOU program. Total responses will then be aggregated to determine overall quality of services upon final participant completion, approximately 3 years after project initiation.

    Time frame: Within 2-4 weeks of PATH4YOU service visit

  4. Participant reported Pregnancy Intention

    Participants will complete the Parenting Attitudes Timing and How important (PATH) validated scale on pregnancy intention. The scale askes participants to express an opinion about having children (yes/no), to rate the importance of pregnancy on a 5 point Likert scale (from very important as a 1 to not at all important as a 5), and to estimate the timeframe in which intend to be pregnant (ranging from within 6 months to more than 5 years from now). Participants will be surveyed at 3 months, 6 months and 12 months after the PATH4YOU service visit.

    Time frame: 3 months, 6 months, and 12 months

  5. Receipt of Pre-Visit Birth Control Decision Aid

    Participants will be asked whether they received the decision aid and whether they used it prior to the visit.

    Time frame: Within 2-4 weeks of PATH4YOU service visit

  6. Continuation of Contraceptive Method

    Participants will be asked whether they are satisfied with, and continuation of, contraceptive method. Participants will be surveyed at 3 months, 6 months and 12 months after the PATH4YOU service visit.

    Time frame: 3 months, 6 months, and 12 months

  7. Unintended pregnancy rate

    The number of unintended pregnancies within 1 year of enrollment will be assessed. Participants will be surveyed at 3 months, 6 months and 12 months after the PATH4YOU service visit.

    Time frame: 3 months, 6 months, and 12 months

Secondary outcomes

  1. Number of women receiving PATH4YOU bundle

    The number of participants in each county will be totaled.

    Time frame: 3 years

  2. Impact of demographics and reproductive characteristics

    The sociodemographic and reproductive characteristics of participants, including participant self-reported age, race, ethnicity, gender, orientation, type of insurance, and zip code, will be evaluated to determine potential correlation with contraceptive method choice.

    Time frame: 3 years

  3. Contraceptive choice

    Of the women not desiring pregnancy, the percentage of women choosing each contraceptive method will be evaluated.

    Time frame: 3 years

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05216003
Lead sponsor
Indiana University
Responsible party
Tracey Wilkinson (Associate Professor, Department of Obstetrics & Gynecology, Indiana University) — Principal investigator
First posted
Jan 31, 2022
Start date
Sep 2, 2021
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 8, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion